Moderna has announced that its manufacturing facility in Harwell, Oxfordshire, the Moderna Innovation and Technology Centre (MITC), has been granted a Manufacturer’s/Importer’s Authorisation (MIA) by the Medicines and Healthcare products Regulatory Agency (MHRA). With the manufacturer’s licence now in place, the company can move forward with commercial mRNA vaccine manufacture, which will be subject to…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
